AbCellera Biologics Inc.
ABCL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $108 | $92 | $159 | $156 |
| Short-Term Investments | $413 | $461 | $446 | $469 |
| Receivables | $41 | $153 | $127 | $92 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $133 | $36 | $33 | $34 |
| Total Curr. Assets | $695 | $742 | $765 | $751 |
| Property Plant & Equip (Net) | $427 | $424 | $347 | $340 |
| Goodwill | $48 | $48 | $48 | $48 |
| Intangibles | $39 | $40 | $41 | $42 |
| Long-Term Investments | $93 | $90 | $82 | $82 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $53 | $57 | $62 | $97 |
| Total NC Assets | $661 | $660 | $579 | $609 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,356 | $1,402 | $1,344 | $1,361 |
| Liabilities | – | – | – | – |
| Payables | $53 | $32 | $33 | $34 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $16 | $25 | $26 | $21 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $69 | $67 | $75 | $77 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $175 | $179 | $171 | $156 |
| Deferred Tax Liab, NC | $10 | $10 | $10 | $10 |
| Other NC Liab. | $1 | $2 | $2 | $1 |
| Total NC Liab. | $323 | $328 | $246 | $228 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $142 | $68 | $65 |
| Total Liabilities | $392 | $395 | $321 | $304 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $794 | $792 | $790 | $777 |
| Retained Earnings | -$21 | $37 | $71 | $117 |
| AOCI | -$3 | -$3 | -$7 | -$4 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $964 | $1,007 | $1,023 | $1,056 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,356 | $1,402 | $1,344 | $1,361 |
| Net Debt | -$108 | -$92 | -$159 | -$156 |